Volume 1, Issue 2 (5-2013)                   J. Pediatr. Rev 2013, 1(2): 80-87 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ghaffari J, Rezaee S A, Gharagozlou M. Chédiak–Higashi syndrome . J. Pediatr. Rev 2013; 1 (2) :80-87
URL: http://jpr.mazums.ac.ir/article-1-49-en.html
1- Mazandaran University of Medical Sciences, Sari, Iran
2- Mashhad University of Medical Sciences , RezaeeR@mums.ac.ir
3- Tehran University of Medical Sciences, Shariati Hospital, Tehran, Iran
Abstract:   (21468 Views)
Chédiak-Higashi syndrome is a rare autosomal recessive congenital immunodeficiency mainly characterized by a condition called oculo-cutaneous albinism. The affected subjects have light-colored hair, vision problems, blood clotting (coagulation) abnormalities and in adulthood varying neurologic disorders. Recurrent infections, particularly viral infection with other disorders in childhood are usually life threatening. It has demonstrated mutations throughout the CHS1/LYST gene. The nature of the mutation can be a predictor of the severity of the disease. The current therapeutic options are: Antibiotics, chemotherapy and bone marrow transplantation. This review will discuss the clinical and molecular aspects of this syndrome for better understanding of the factors that may cause abnormalities.
Full-Text [PDF 286 kb]   (10960 Downloads)    
Type of Study: Narrative Review |
Received: 2013/05/19 | Accepted: 2013/09/16 | Published: 2013/09/16

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Pediatrics Review

Designed & Developed by : Yektaweb